Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus

Detalles Bibliográficos
Autores principales: Robinson, Warner, McLellan, Beth N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641548/
https://www.ncbi.nlm.nih.gov/pubmed/37965187
http://dx.doi.org/10.1016/j.jdcr.2023.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641548/
https://www.ncbi.nlm.nih.gov/pubmed/37965187
http://dx.doi.org/10.1016/j.jdcr.2023.09.006

Ejemplares similares